Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Clinical Study Sites-TLD 1433 in the United States.
View:
Post by Infinity on Apr 04, 2022 3:14pm

Clinical Study Sites-TLD 1433 in the United States.

I was wondering if there was any updates on the Clinical Study sites on their Web Page.  Some of the Clinical Study Sites do not even have TLD1433 or PDT as an option in the Clinical Trials

  1.  University of Chicago Link:  Clinical study sites

https://www.uchicagomedicine.org/find-a-clinical-trial?page=1&conditionId=d4bf1868b7104275acd1089ebce4959a


  1.  Urology San Antonio Study Site link

https://www.urologysanantonio.com/clinical-trials-current-studies



  1. University of Wisconsin Madison:  Mentions a clinical study using PDT 


https://clinicaltrials.uwhealth.org/studies?commit=Search&page=2&search%5Bcategory%5D=3&search%5Bgender%5D=&search%5Bhealthy_volunteers%5D=&search%5Bq%5D=bladder&utf8=%E2%9C%93


  1. Carolina Urologic center: Mentions their clinical study with Theralase and end date May 2022

https://carolinaurologicresearchcenter.com/current-trials/current-trials-bladder-cancer/



  1. Midlantic Urology:  Link has Theralase Tech as part of their Clinical Trials


https://midlanticurology.com/clinical-research


  1.  Urology associates Nashville TN


https://www.urologynashville.com/centers-of-excellence/research/


  1.  Urology Virginia

https://www.uro.com/about-us/clinical-trials-research/


 

 
Comment by SouthernTierTom on Apr 04, 2022 8:03pm
Will one of the "experts" hear..answer that darn phone: I was wondering if there was any updates on the Clinical Study sites on their Web Page.  Some of the Clinical Study Sites do not even have TLD1433 or PDT as an option in the Clinical Trials  University of Chicago Link:  Clinical study sites https://www.uchicagomedicine.org/find-a-clinical-trial?page=1 ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250